US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Mural Oncology plc - Ordinary Shares
(NQ:
MURA
)
2.040
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mural Oncology plc - Ordinary Shares
< Previous
1
2
3
4
Next >
MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
↗
August 13, 2024
MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
August 13, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
July 31, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024
↗
May 14, 2024
Mural Oncology just reported results for the first quarter of 2024.
Via
InvestorPlace
MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023
↗
March 26, 2024
Mural Oncology just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
June 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
MURA Stock Earnings: Mural Oncology Reported Results for Q3 2023
↗
December 18, 2023
Mural Oncology just reported results for the third quarter of 2023.
Via
InvestorPlace
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
May 23, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
March 26, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 04, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks to Invest in for Big Gains in 2024
↗
February 02, 2024
These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in January
↗
January 15, 2024
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.
Via
InvestorPlace
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024
From
Mural Oncology, Inc.
Via
GlobeNewswire
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
↗
November 20, 2023
Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
November 20, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
November 17, 2023
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via
Benzinga
Dear LI Stock Fans, Mark Your Calendars for Dec. 4
↗
November 17, 2023
Li Auto stock fans are preparing for a major catalyst when the company's shares join the Hang Seng Index starting on Dec. 4.
Via
InvestorPlace
Why Is ChargePoint (CHPT) Stock Down 32% Today?
↗
November 17, 2023
ChargePoint stock is falling on Friday as investors in CHPT shares react to preliminary earnings data for the third quarter of the year.
Via
InvestorPlace
Why Is Bone Biologics (BBLG) Stock Down 38% Today?
↗
November 17, 2023
Bone Biologics stock is falling on Friday as shares of BBLG give up some of the gains they saw during an unexpected rally on Thursday!
Via
InvestorPlace
< Previous
1
2
3
4
Next >
